Matrix metalloproteinase

tvScientific Launches Retail Performance TV

Retrieved on: 
Wednesday, November 15, 2023

PASADENA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- tvScientific , the preeminent performance advertising platform for connected TV (CTV), today announced the launch of Retail Performance TV, a retail media solution that enables advertisers to leverage granular retail data including foot traffic, purchase history and location-specific interests to target CTV ad campaigns on a cost-per-outcome basis.

Key Points: 
  • PASADENA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- tvScientific , the preeminent performance advertising platform for connected TV (CTV), today announced the launch of Retail Performance TV, a retail media solution that enables advertisers to leverage granular retail data including foot traffic, purchase history and location-specific interests to target CTV ad campaigns on a cost-per-outcome basis.
  • By blending synthetic retail data from a variety of sources in tvScientific’s CTV targeting and measurement platform, retailers can target television advertisements to specific households according to their search and purchase history while factoring in retail store visits, unlocking unheard-of levels of performance.
  • “Retail Performance TV leverages the most powerful retail-level data - purchase history and geography - to serve ads on the most powerful channel available: television,” said Jason Fairchild, CEO of tvScientific.
  • “The ability to activate this kind of rich data on a one-to-one basis on the biggest, brightest screen in the household represents an entirely new capability for advertisers.”
    The launch of Retail Performance TV follows the ongoing transition of the $72 billion TV advertising market to programmatic execution, as technologies emerge that enable the buying and measurement of TV advertising in a manner similar to the $200 billion search and social media market.

Mark Farrah Associates Assessed the 2024 Competitive Medicare Advantage Market

Retrieved on: 
Monday, October 30, 2023

Mark Farrah Associates (MFA), www.markfarrah.com , released an analysis presenting a brief assessment of the 2024 Medicare market landscape.

Key Points: 
  • Mark Farrah Associates (MFA), www.markfarrah.com , released an analysis presenting a brief assessment of the 2024 Medicare market landscape.
  • With the 2024 Annual Election Period (AEP) well underway, health plans invested in Medicare Advantage (MA) business have been eagerly marketing their products to attract more seniors.
  • MFA reported 5,805 distinct MA plan offerings are in the market lineup for the current 2024 AEP.
  • This includes MA plans, Medicare Advantage with prescription drug plans (MAPDs), Medicare/Medicaid plans (MMPs), and Special Needs Plans (SNPs).

Alcoa Corporation Reports Third Quarter 2023 Results

Retrieved on: 
Wednesday, October 18, 2023

Net loss attributable to Alcoa Corporation was $168 million, or $0.94 per share.

Key Points: 
  • Net loss attributable to Alcoa Corporation was $168 million, or $0.94 per share.
  • Additionally, the third quarter results include the benefit of a $58 million valuation allowance reversal on the deferred tax assets of the Company’s subsidiaries in Iceland.
  • Alcoa disclosed before an August 2023 deadline its progress for applicable facilities, in accordance with the ICMM Conformance Protocol.
  • Alcoa will hold its quarterly conference call at 5:00 p.m. Eastern Daylight Time (EDT) on Wednesday, October 18, 2023, to present third quarter 2023 financial results and discuss the business, developments, and market conditions.

Regenerex Pharma, Inc. Corporate and Management Structure Update

Retrieved on: 
Thursday, September 28, 2023

Regenerex Pharma, Inc. (OTC: RGPX), announces the establishment of its comprehensive management team and the commencement of the Company manufacturing plans in Q4 2023.

Key Points: 
  • Regenerex Pharma, Inc. (OTC: RGPX), announces the establishment of its comprehensive management team and the commencement of the Company manufacturing plans in Q4 2023.
  • Regenerex Pharma’s products heal wounds effectively with its proprietary innovative formulas in the shortest period of time to minimize the chances of future complications.
  • The products have shown to be very effective in healing chronic wounds in multiple clinical evaluations with 95% of wounds demonstrating 100% closure within 90 days.
  • All of our products feature our proprietary QBx™ ingredients which contribute to setting up a suitable environment to allow wounds to close.

DolCas Biotech Obtains its First Non-GMO Project Verified Label for MMP-50®

Retrieved on: 
Wednesday, September 13, 2023

LANDING, N.J., Sept. 13, 2023 /PRNewswire/ -- DolCas Biotech, LLC obtains its first Non-GMO Project-verified label for MMP-50®, a cold-processed, DNA-verified, and clinically researched New England green lipped mussel extract for human and pet health. MMP-50 is one of seven clinically researched ingredients in the innovative company's portfolio, and while MMP-50 is the first to receive the backing of the prestigious certification, CEO and founder, K. G. Rao affirms the company's plans to pursue the certification across its portfolio.

Key Points: 
  • LANDING, N.J., Sept. 13, 2023 /PRNewswire/ -- DolCas Biotech, LLC obtains its first Non-GMO Project-verified label for MMP-50®, a cold-processed, DNA-verified, and clinically researched New England green lipped mussel extract for human and pet health.
  • The transparency efforts the Non-GMO Project spearheaded on the food front has translated to the supplement market.
  • DolCas voluntarily submitted MMP-50 for compliance evaluation with the Non-GMO Project standard.
  • Like the Non-GMO Verified Project, the ASC certificate is the most highly merited of third-party credentialing in its category.

tvScientific Launches Cost-Per-Outcome CTV Ad Buying Through Partners

Retrieved on: 
Thursday, August 17, 2023

PASADENA, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- tvScientific , the performance advertising platform for connected TV (CTV), announced today that brands and advertisers can now purchase CTV ad campaigns on a Cost-Per-Outcome (CPO) basis through leading partners Awin/Shareasale, Commission Junction, Impact, Partnerize, Partnerstack and Rakuten.

Key Points: 
  • PASADENA, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- tvScientific , the performance advertising platform for connected TV (CTV), announced today that brands and advertisers can now purchase CTV ad campaigns on a Cost-Per-Outcome (CPO) basis through leading partners Awin/Shareasale, Commission Junction, Impact, Partnerize, Partnerstack and Rakuten.
  • With CPO buying through tvScientific’s partners, advertisers are able to align their actual ad spend to marketing goals and only pay for outcomes that align with their desired results.
  • The new capability solidifies tvScientific as the leading global technology company for driving measurable ROI through CTV campaigns.
  • “We are very pleased with our growing roster of customers, partners and technical capabilities, and look forward to showing more brands across industries what’s possible with CTV.”

Alcoa Corporation Reports Second Quarter 2023 Results

Retrieved on: 
Wednesday, July 19, 2023

Third-party shipments in the second quarter of 2023 include alumina purchased to offset lower production.

Key Points: 
  • Third-party shipments in the second quarter of 2023 include alumina purchased to offset lower production.
  • Western Australia Mine Plan Approvals: During the second quarter of 2023, the Company continued to work with relevant state government agencies to support the annual mine approvals process.
  • The second quarter 2023 included favorable foreign currency gains of $40 million that may not recur.
  • Alcoa will hold its quarterly conference call at 5:00 p.m. Eastern Daylight Time (EDT) on Wednesday, July 19, 2023, to present second quarter 2023 financial results and discuss the business, developments, and market conditions.

Kochava Publisher’s Suite Selected by Major Industry Publishers

Retrieved on: 
Tuesday, June 20, 2023

Kochava , the leading real-time data solutions company for omni-channel attribution and measurement, today announced the Kochava Publisher’s Suite has been selected by and successfully integrated with major platforms and publishers.

Key Points: 
  • Kochava , the leading real-time data solutions company for omni-channel attribution and measurement, today announced the Kochava Publisher’s Suite has been selected by and successfully integrated with major platforms and publishers.
  • “This marks a significant milestone for our Publisher’s Suite since we launched last year,” said Charles Manning, Founder and CEO, Kochava.
  • The Kochava Publisher’s Suite also seamlessly integrates with all other mobile measurement partners (MMPs) to offer a flexible solution for publishers.
  • The Kochava Publisher’s Suite provides clear-labeled ad measurement tech for owned and operated inventory across leading platform-direct and publisher-direct offerings.

Late-Breaking Turn Biotechnologies Presentation at ISID to Show Cell Reprogramming with ERA™ Technology Renews Skin

Retrieved on: 
Wednesday, May 10, 2023

MOUNTAIN VIEW, Calif., May 10, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell reprogramming company developing novel mRNA medicines for untreatable, age-related conditions, has been invited to present data showing that its epigenetic reprogramming technology rejuvenates human skin.

Key Points: 
  • MOUNTAIN VIEW, Calif., May 10, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell reprogramming company developing novel mRNA medicines for untreatable, age-related conditions, has been invited to present data showing that its epigenetic reprogramming technology rejuvenates human skin.
  • Turn Bio's late-breaking abstract was accepted for presentation during the prestigious International Societies for Investigative Dermatology (ISID) Meeting, in Tokyo, Japan.
  • Data will show that transient reprogramming with Turn Bio's Epigenetic Reprogramming of Aging (ERA™) technology rejuvenates cells within the extracellular matrix (ECM), resulting in comprehensive changes related to improved skin quality and structure.
  • Turn Bio data will be presented by Dr. Edward Hsia, vice president of Dermatology at Turn Bio.

Bidease Expands Executive Team with Betty Wan as VP of Partnerships

Retrieved on: 
Tuesday, May 2, 2023

NEW YORK, May 2, 2023 /PRNewswire/ -- Bidease , a leading mobile AdTech company, has announced that Betty Wan is joining it as Vice President of Partnerships.

Key Points: 
  • NEW YORK, May 2, 2023 /PRNewswire/ -- Bidease , a leading mobile AdTech company, has announced that Betty Wan is joining it as Vice President of Partnerships.
  • In this role, Betty Wan will be responsible for supporting Bidease's growth globally by building and growing solid partnerships in the mobile ecosystem, including SSPs, MMPs, DMPs, BI tools, and others.
  • Her expertise in mobile advertising will be invaluable to Bidease as we continue to expand our inventory footprint and platform partnerships.
  • As part of this mission, I look forward to building and nurturing strong relationships with our top ecosystem partners," said Wan.